Please login to the form below

Not currently logged in


This page shows the latest Jakafi news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD

FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD

GVHD. In this trial, Jakafi-treated patients experienced significantly greater overall response rates (ORR) compared to BAT at week 24. ... With a priority review in hand, the review of Jakafi in chronic GVHD is shortened to six months, compared to ten

Latest news

More from news
Approximately 6 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....